Your Health, We Care
Palbociclib is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:
• an aromatase inhibitor as initial endocrine-based therapy; or
• fulvestrant in patients with disease progression following endocrine therapy.
from FDA，2022.12
LuciusVersionofPalbociclib:DosageandAdministration,Indications,PrecautionsIndicationCapivasertib is ···【more】
Recommended：62025-05-12
Lucius Version of Palbociclib: Dosage and Administration, Indications, PrecautionsIndicationsPalboci···【more】
Recommended：142025-02-12
LuciusVersionofPalbociclib:DosageandAdministration,Indications,PrecautionsIndicationCapivasertib is a kinase inhibitor. In combination with fulvestrant, it is indicated for the tre···【more】
Article source：Lucius LaosRelease date：2025-12-05Recommended：6
Lucius Version of Palbociclib: Dosage and Administration, Indications, PrecautionsIndicationsPalbociclib is a kinase inhibitor indicated for the treatment of adult patients with ho···【more】
Article source：Lucius LaosRelease date：2025-12-02Recommended：14
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
